Novo Nordisk’s blockbuster drug exports drive Denmark’s GDP growth above eurozone levels, per Danske Bank, fueling a trade surplus and potentially strengthening…
Scientists are tracking Ebola survivors in remote mountains to harvest antibodies for a cure, offering new hope against the virus and potential…
Apotex Health's planned C$1.2 billion Toronto IPO underscores strong demand for Canadian healthcare equities, with potential to lift the S&P/TSX Composite Index…
Big Caring, Malaysia’s top pharma retailer, targets a $750 million IPO, marking a major test for equity capital markets in the region.
Apotex Health's IPO on the TSX signals a thaw in Canadian public markets, potentially reviving equity issuance and investor sentiment.
Apotex's Toronto IPO filing advances the Canadian drugmaker's public listing, potentially boosting the TSX and healthcare sector sentiment.
Astellas Pharma shares fell in Tokyo after the company’s five-year strategic plan disappointed investors with modest growth targets and pipeline uncertainty.
Denmark's GDP outlook upgrade driven by pharmaceutical exports underscores the economic influence of Novo Nordisk's Ozempic and Wegovy, lifting growth expectations and…